TGA Approval

SALOFALK GRANULES mesalazine 3g modified release granules sachet (214810)

ARTG ID

214810

ARTG Name

SALOFALK GRANULES mesalazine 3g modified release granules sachet

Sponsor

Dr Falk Pharma Australia Pty Ltd

ARTG Date

July 2, 2014

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

DR FALK PHARMA AUSTRALIA PTY LTD

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2021-CMI-01060-1

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2021-PI-01051-1

Ingredient Name

mesalazine

Empowering clinical research with data-driven insights and AI-powered tools.

SALOFALK GRANULES mesalazine 3g modified release granules sachet (214810) - TGA 批准文号 | MedPath